Texas 2023 - 88th Regular

Texas House Bill HB2767 Latest Draft

Bill / Engrossed Version Filed 05/06/2023

Download
.pdf .doc .html
                            88R7685 JSC-F
 By: Klick H.B. No. 2767


 A BILL TO BE ENTITLED
 AN ACT
 relating to the sharing of controlled substance prescription
 monitoring information between the Texas State Board of Pharmacy
 and the Health and Human Services Commission for the state Medicaid
 program.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 481.076, Health and Safety Code, is
 amended by amending Subsections (a), (d), and (k) and adding
 Subsections (a-3) and (l) to read as follows:
 (a)  The board may not permit any person to have access to
 information submitted to the board under Section 481.074(q) or
 481.075 except:
 (1)  the board, the Texas Medical Board, the Texas
 Department of Licensing and Regulation, with respect to the
 regulation of podiatrists, the State Board of Dental Examiners, the
 State Board of Veterinary Medical Examiners, the Texas Board of
 Nursing, or the Texas Optometry Board for the purpose of:
 (A)  investigating a specific license holder; or
 (B)  monitoring for potentially harmful
 prescribing or dispensing patterns or practices under Section
 481.0762;
 (2)  an authorized employee of the board engaged in the
 administration, investigation, or enforcement of this chapter or
 another law governing illicit drugs in this state or another state;
 (3)  the department or other law enforcement or
 prosecutorial official engaged in the administration,
 investigation, or enforcement of this chapter or another law
 governing illicit drugs in this state or another state, if the board
 is provided a warrant, subpoena, or other court order compelling
 the disclosure;
 (4)  a medical examiner conducting an investigation;
 (5)  provided that accessing the information is
 authorized under the Health Insurance Portability and
 Accountability Act of 1996 (Pub. L. No. 104-191) and regulations
 adopted under that Act:
 (A)  a pharmacist or a pharmacist-intern,
 pharmacy technician, or pharmacy technician trainee, as defined by
 Section 551.003, Occupations Code, acting at the direction of a
 pharmacist, who is inquiring about a recent Schedule II, III, IV, or
 V prescription history of a particular patient of the pharmacist;
 or
 (B)  a practitioner who:
 (i)  is a physician, dentist, veterinarian,
 podiatrist, optometrist, or advanced practice nurse or is a
 physician assistant described by Section 481.002(39)(D) or an
 employee or other agent of a practitioner acting at the direction of
 a practitioner; and
 (ii)  is inquiring about a recent Schedule
 II, III, IV, or V prescription history of a particular patient of
 the practitioner;
 (6)  a pharmacist or practitioner who is inquiring
 about the person's own dispensing or prescribing activity or a
 practitioner who is inquiring about the prescribing activity of an
 individual to whom the practitioner has delegated prescribing
 authority;
 (7)  one or more states or an association of states with
 which the board has an interoperability agreement, as provided by
 Subsection (j);
 (8)  a health care facility certified by the federal
 Centers for Medicare and Medicaid Services; [or]
 (9)  the patient, the patient's parent or legal
 guardian, if the patient is a minor, or the patient's legal
 guardian, if the patient is an incapacitated person, as defined by
 Section 1002.017(2), Estates Code, inquiring about the patient's
 prescription record, including persons who have accessed that
 record; or
 (10)  the Health and Human Services Commission or the
 commission's designee for the purpose of meeting the standards
 required by 42 U.S.C. Section 1396w-3a for a qualified prescription
 drug monitoring program.
 (a-3)  A person authorized to receive information under
 Subsection (a)(10) may only access information necessary to comply
 with 42 U.S.C. Section 1396w-3a for the purpose of administering
 the medical assistance program under Chapter 32, Human Resources
 Code.
 (d)  Information submitted to the board under this section
 may be used only for:
 (1)  the administration, investigation, or enforcement
 of this chapter or another law governing illicit drugs in this state
 or another state;
 (2)  investigatory, evidentiary, or monitoring
 purposes in connection with the functions of an agency listed in
 Subsection (a)(1);
 (3)  the prescribing and dispensing of controlled
 substances by a person listed in Subsection (a)(5); [or]
 (4)  dissemination by the board to the public in the
 form of a statistical tabulation or report if all information
 reasonably likely to reveal the identity of each patient,
 practitioner, or other person who is a subject of the information
 has been removed; or
 (5)  the administration of the medical assistance
 program under Chapter 32, Human Resources Code.
 (k)  A person authorized to access information under
 Subsection (a)(4), [or] (5), or (10) who is registered with the
 board for electronic access to the information is entitled to
 directly access the information available from other states
 pursuant to an interoperability agreement described by Subsection
 (j).
 (l)  The board shall enter into and maintain a data-sharing
 agreement with the Health and Human Services Commission for the
 purpose of complying with 42 U.S.C. Section 1396w-3a(b). The
 agreement must include a provision requiring the board and the
 commission to timely share information to allow the commission
 sufficient time to prepare and submit the annual report to the
 United States Secretary of Health and Human Services described by
 42 U.S.C. Section 1396w-3a(e).
 SECTION 2.  The Texas State Board of Pharmacy and the Health
 and Human Services Commission shall enter into the data-sharing
 agreement described by Section 481.076(l), Health and Safety Code,
 as added by this Act, not later than January 1, 2024.
 SECTION 3.  If before implementing any provision of this Act
 a state agency determines that a waiver or authorization from a
 federal agency is necessary for implementation of that provision,
 the agency affected by the provision shall request the waiver or
 authorization and may delay implementing that provision until the
 waiver or authorization is granted.
 SECTION 4.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution. If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2023.